Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes.

Chhabria S, Takle V, Sharma N, Kharkar P, Pansare K, Tripathi A, Tripathi A, Bhartiya D

DOI: 10.1186/s13048-022-01043-8
Published: 2022 Oct 21
Container: Journal of ovarian research
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13048-022-01043-8,
  title = {Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes.},
  author = {Chhabria S and Takle V and Sharma N and Kharkar P and Pansare K and Tripathi A and Tripathi A and Bhartiya D},
  year = {2022},
  journal = {Journal of ovarian research},
  doi = {10.1186/s13048-022-01043-8},
  url = {https://doi.org/10.1186/s13048-022-01043-8}
}

RIS

TY  - JOUR
TI  - Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes.
AU  - Chhabria S
AU  - Takle V
AU  - Sharma N
AU  - Kharkar P
AU  - Pansare K
AU  - Tripathi A
AU  - Tripathi A
AU  - Bhartiya D
PY  - 2022
JO  - Journal of ovarian research
DO  - 10.1186/s13048-022-01043-8
UR  - https://doi.org/10.1186/s13048-022-01043-8
ER  -

APA

S, C., V, T., N, S., P, K., K, P., A, T., A, T., & D, B. (2022). Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes.. Journal of ovarian research. https://doi.org/10.1186/s13048-022-01043-8

Source records

pubmed · retrieved 2026-09-25T20:47:46.810Z